Mark J. Fitzpatrick

Director/Board Member at ALLENA PHARMACEUTICALS, INC.

61 year

Health Technology

Health Services

Technology Services

Profile

Mark J.
Fitzpatrick currently works at Versantis AG, as Chief Executive Officer & Director from 2021 and Allena Pharmaceuticals, Inc., as Independent Director from 2021.
Mr. Fitzpatrick also formerly worked at Repligen Corp., as Principal, Diacrin, Inc. (Delaware), as Chief Financial Officer & Vice President from 1991 to 1998, Dynogen Pharmaceuticals, Inc., as Chief Financial Officer from 1998 to 2009, Proteon Therapeutics, Inc., as Chief Financial Officer & Vice President from 2007 to 2011, Aegerion Pharmaceuticals, Inc., as Chief Financial Officer from 2011 to 2015, Chiasma, Inc., as President & Chief Financial Officer from 2019 to 2021, RenaMed Biologics, Inc., as Chief Financial Officer, WorldStreet Corp., as Chief Financial Officer & Senior Vice President from 1998 to 2002, and Arthur Andersen LLP, as Senior Auditor.
Mr. Fitzpatrick received his undergraduate degree in 1984 from Boston College.

Mark J. Fitzpatrick active positions

Companies	Position	Start
ALLENA PHARMACEUTICALS, INC.	Director/Board Member	2021-04-05

All active positions of Mark J. Fitzpatrick

Former positions of Mark J. Fitzpatrick

Companies	Position	End
CHIASMA, INC.	Chief Executive Officer	2019-06-16
AEGERION PHARMACEUTICALS, INC.	Director of Finance/CFO	2015-05-31
PROTARA THERAPEUTICS, INC.	Director of Finance/CFO	2011-04-30
Dynogen Pharmaceuticals, Inc. Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dynogen Pharmaceuticals, Inc. develops and manufactures drugs. The company makes drugs for genitourinary and gastrointestinal disorders. It also makes drugs for constipation, Irritable Bowel Syndrome and overactive bladder. Dynogen Pharmaceuticals was founded by Lee R. Brettman in 2002 and is located in Waltham, MA.	Director of Finance/CFO	2009-11-12
RenaMed Biologics, Inc. RenaMed Biologics, Inc. Medical/Nursing ServicesHealth Services RenaMed Biologics, Inc. provided clinical cellular therapy. The company was founded by H. David Humes, James P. Sherblom and Richard A. Andrews in 1995 and was headquartered in Lincoln, RI.	Director of Finance/CFO	-

See the detail of Mark J. Fitzpatrick's experience

Training of Mark J. Fitzpatrick

Boston College

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mark J. Fitzpatrick's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
REPLIGEN CORPORATION	Health Technology
ALLENA PHARMACEUTICALS, INC.	Health Technology

Private companies	8
Diacrin, Inc. (Delaware) Diacrin, Inc. (Delaware) Medical SpecialtiesHealth Technology Diacrin, Inc. develops human cell transplant therapeutic products. The company is headquartered in Wilmington, DE.	Health Technology
Dynogen Pharmaceuticals, Inc. Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dynogen Pharmaceuticals, Inc. develops and manufactures drugs. The company makes drugs for genitourinary and gastrointestinal disorders. It also makes drugs for constipation, Irritable Bowel Syndrome and overactive bladder. Dynogen Pharmaceuticals was founded by Lee R. Brettman in 2002 and is located in Waltham, MA.	Health Technology
Proteon Therapeutics, Inc. Proteon Therapeutics, Inc. BiotechnologyHealth Technology Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F. Nicholas Franano and William P. Whitaker in 2001 and is headquartered in Waltham, MA.	Health Technology
Aegerion Pharmaceuticals, Inc. Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer, Gerald L. Wisler and William H. Lewis in 2005 and is headquartered in Cambridge, MA.	Health Technology
Chiasma, Inc. Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Chiasma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of oral forms of therapies that are available by injection. Its products include octreotide capsules. The company was founded by Shmuel A. Ben-Sasson and Guy Yachin in 2001 and is headquartered in Needham, MA.	Health Technology
RenaMed Biologics, Inc. RenaMed Biologics, Inc. Medical/Nursing ServicesHealth Services RenaMed Biologics, Inc. provided clinical cellular therapy. The company was founded by H. David Humes, James P. Sherblom and Richard A. Andrews in 1995 and was headquartered in Lincoln, RI.	Health Services
WorldStreet Corp. WorldStreet Corp. Packaged SoftwareTechnology Services WorldStreet Corp. develops enterprise software applications. The American company was founded by Paul I. Walborsky.	Technology Services
Arthur Andersen LLP Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL.	Commercial Services